Philip J. DiSaia

University of California, Irvine — United States

Medicine · Health Sciences

77h-index56.0kcitations360works0.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Ovarian cancer diagnosis and treatment(118), Endometrial and Cervical Cancer Treatments(86), Cervical Cancer and HPV Research(34), Estrogen and related hormone effects(28), Cancer Genomics and Diagnostics(22)

Publications329 total

Phase III Randomized Trial of Maintenance Taxanes Versus Surveillance in Women With Advanced Ovarian/Tubal/Peritoneal Cancer: A Gynecologic Oncology Group 0212:NRG Oncology Study
Journal of Clinical Oncology·2022· 6 citedOpen Access
Integrated genomic analyses of ovarian carcinoma
UNC Libraries·2020Open Access
Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer
Journal of Clinical Oncology·2019· 462 citedOpen Access
Final overall survival (OS) analysis of an international randomized trial evaluating bevacizumab (BEV) in the primary treatment of advanced ovarian cancer: A NRG oncology/Gynecologic Oncology Group (GOG) study.
Journal of Clinical Oncology·2018· 37 cited
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
eScholarship (California Digital Library)·2017Open Access
Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240)
The Lancet·2017· 658 citedOpen Access
A phase III trial of maintenance therapy in women with advanced ovarian/fallopian tube/peritoneal cancer after a complete clinical response to first-line therapy: An NRG oncology study
Gynecologic Oncology·2017· 18 cited
Abstract TMEM-021: CORRELATION BETWEEN DRUG SENSITIVITY AND METABOLOMIC SIGNATURES WITH OBJECTIVE RESPONSE (OR), TIME TO PROGRESSION (TTP), AND OVERALL SURVIVAL (OS) IN ADVANCED EPITHELIAL OVARIAN CANCER (EOC): A PHASE II STUDY
2017
'When will my cancer be addressed?' A retrospective evaluation of factors that contribute to delay in care for women with ovarian cancer
Gynecologic Oncology·2016Open Access
Full-Thickness Skin Grafts for Neovaginal Construction in Mayer–Rokitansky–Küster–Hauser Syndrome
Journal of Gynecologic Surgery·2015· 3 cited
NRG Oncology Research Opportunities Within the New National Clinical Trials Network
Seminars in Oncology·2014· 6 citedOpen Access
Incorporation of Anti-angiogenic Therapies in the Treatment of Epithelial Ovarian Cancer: Current Perspectives and Future Directions
Current Angiogenesis·2012
Outcomes of High-Dose-Rate Interstitial Brachytherapy in the Treatment of Locally Advanced Cervical Cancer: Long-term Results
International Journal of Radiation Oncology*Biology*Physics·2012· 53 citedOpen Access
Should be para-aortic lymphadenectomy up to the level of the renal vein mandatory in ovarian cancer patients presenting ovarian cancer presumed to be confined to the ovary?
Gynecologic Oncology·2012
Comprar Clinical Gynecologic Oncology (Online And Print) | W. Creasman | 9780323074193 | Mosby
2012· 2 cited
Integrated genomic analyses of ovarian carcinoma
Nature·2011· 8.0k citedOpen Access
First-Line Therapy in Ovarian Cancer Trials
International Journal of Gynecological Cancer·2011· 83 cited
Fertility preserving options in patients with gynecologic malignancies
American Journal of Obstetrics and Gynecology·2011· 99 citedOpen Access
Predicting Parametrial Involvement in Endometrial Cancer
Obstetrics and Gynecology·2010· 11 cited
Long-term Results of High-dose-rate Interstitial Brachytherapy in the Treatment of Carcinoma of the Cervix
International Journal of Radiation Oncology*Biology*Physics·2010Open Access
page 1 of 17Next →

Frequent Co-authors

William T. Creasman(13), John A. Blessing(13), Michael L. Berman(11), Robert A. Burger(6), Krishnansu S. Tewari(5), J.T. Thigpen(5), Bradley J. Monk(5), Howard D. Homesley(5), John K. Chan(5), Brian N. Bundy(5), Alberto Manetta(5), Frederick B. Stehman(4), Wesley C. Fowler(4), Francis J. Major(4), Kathryn Osann(4), Vera Loizzi(4), Michael J. Birrer(3), Richard C. Boronow(3), C. Paul Morrow(3), Richard J. Zaino(3)